Lone Star Value Management’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Lone Star Value Management’s Portfolio PLXP Stock Details PLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$2.49M	Sell	21,458 -1,250	-6%	-$122K	4.72%	6
2016 Q2	$1.8M	Sell	22,708 -4,518	-17%	-$392K	3.62%	8
2016 Q1	$2.07M	Sell	27,226 -1,504	-5%	-$95.6K	4.99%	8
2015 Q4	$2.57M	Buy	28,730 +16,855	+142%	+$1.62M	4.76%	9
2015 Q3	$1.33M	Sell	11,875 -6,875	-37%	-$791K	2.54%	12
2015 Q2	$1.91M	Buy	+18,750	New	+$1.94M	2.76%	11

Other funds holding PLXP

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

TCP

Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LOAMU

Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return

Emerald Acquisition Seattle, Washington $51.8B AUM

TCM

Timpani Capital Management Milwaukee, Wisconsin $209M AUM 62.15% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Lone Star Value Management's PLXP Position: Q3 2016 in Review

Lone Star Value Management reduced its PLx Pharma Inc. Common Stock (PLXP) stake by 5.5% in Q3 2016, selling an estimated $122K and leaving 21,458 shares worth $2.49M. The position accounts for 4.72% of the portfolio, ranked #6.

Lone Star Value Management first reported a position in PLXP in Q2 2015 and has held it in 6 quarters since. The position peaked at $2.57M in Q4 2015. 32 funds tracked by Wall St. Rank hold PLXP as of Q3 2016.

Lone Star Value Management held 21,458 shares of PLx Pharma Inc. Common Stock worth $2.49M as of Q3 2016.
Lone Star Value Management sold 1,250 PLx Pharma Inc. Common Stock shares in Q3 2016, an estimated $122K.
PLx Pharma Inc. Common Stock made up 4.72% of Lone Star Value Management's portfolio in Q3 2016, its #6 holding.
Lone Star Value Management first reported a position in PLx Pharma Inc. Common Stock in Q2 2015 and has held it in 6 quarters since.
Lone Star Value Management's PLx Pharma Inc. Common Stock position peaked at $2.57M in Q4 2015.
32 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q3 2016.

Based on Lone Star Value Management's 13F filing for Q3 2016, filed 14 Nov 2016.